Deep Isolation Nuclear, Inc. 8K

Deep Isolation Nuclear, Inc. announced Q2 2026 results, detailing increased R&D-driven losses alongside key milestones including S-1 effectiveness, commencement of OTCQB trading under DBHL, expanded field operations in Texas, over 100 issued patents, and selection as sole industrial partner on three DOE Project GENESIS grants.

On August 6, 2026, Deep Isolation Nuclear, Inc. reported its operational and financial results for the quarter ended June 30, 2026, highlighting that its Form S-1 registration statement was declared effective by the SEC on May 7, 2026, enabling its common stock to become freely tradable, and that its shares subsequently commenced quotation on the OTCQB Venture Market under the ticker DBHL. The company noted key operational milestones, including surpassing 100 issued patents worldwide related to deep borehole nuclear waste disposal technologies, establishing a permanent field presence at the Deep Borehole Demonstration Center near Cameron, Texas to advance a full-scale, at-depth non‑radioactive demonstration of its Universal Canister System, and being selected after quarter end as the sole industrial partner on three U.S. Department of Energy Project GENESIS grants. Financially, Deep Isolation reported Q2 2026 revenue of $1.3 million (down 19% year over year), research and development expense of approximately $1.2 million, a net loss of $3.0 million driven primarily by R&D and SG&A spending, and cash of $19.4 million as of June 30, 2026, with 57,667,113 common shares outstanding as of August 3, 2026.

Filing Facts

CIK

1918080

Ticker

-

Form

8K

Source Type

sec

Accession

0001918080-26-000014

Alert Tier

6